Home › Myasthenia Gravis › Connecticut
Myasthenia Gravis clinical trials in Connecticut
6 studies for Myasthenia Gravis are looking for participants at sites in Connecticut.
Cities in Connecticut
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- University of Connecticut, Farmington
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 25, 2026 · NCT07217587Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- University of Connecticut Health Center - Department of Medicine, Farmington
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 16, 2026 · NCT06463587Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
- Site Number - 1001, New Haven
RecruitingPhase 3
Ages 18 to 80 · All sexes · Updated Jul 30, 2026 · NCT07039916A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Yale New Haven Hospital, New Haven
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Jul 27, 2026 · NCT04951622Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)
- Clinical Trial Site, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Feb 18, 2026 · NCT04202341The EXPLORE MG Registry for Myasthenia Gravis
- Yale-New Haven Hospital, New Haven
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 28, 2025 · NCT03792659From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.